What they say:
A recent study from the Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Frankfurt, Germany shows that “MicroRNA-34a regulates cardiac ageing and function.” This study was published in the 7 March 2013 issue of Nature by Prof Dimmler, Boon, and others.
What we say:
On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Natural product therapy for Myocardial Infarction: Methyl 3,5-dicaffeoyl quinate (MDQ), found in Kalopanax pictus, Salicornia herbacea L., Aster oharai and Solidago virga-aurea var. gigantean, improves myocardial function after myocardial infarction via up-regulation of PNUTS
Significance:
Given that: (1) cardiovascular disease is the leading cause of death worldwide; (2) in India, in 2004, 14.6 lakhs deaths (14% of total deaths) were due to ischemic heart disease; and (3) the global economic cost spent in the treatment of cardiovascular disease in 2011 was little more than 10 billion US dollars, there is an urgent need to find: (i) a way to induce regeneration of adult cardiomyocytes that were lost in Myocardial patients; (ii) a cheaper alternative to the existing expensive drugs; and (iii) a side-effect-free drug.
From Research Findings to Therapeutic Opportunity:
This study suggests a natural product-based cardiac regeneration therapy. Methyl 3,5-dicaffeoyl quinate (MDQ), by increasing the expression of its target gene, it may increase the expression of PNUTS. Thereby, it may: (1) inhibit DNA damage responses, (2) inhibit telomere shortening; and (3) promote cardiomyocyte survival/regeneration.
Methyl 3,5-dicaffeoyl quinate (MDQ), found in Castor-aralia (kalopanax-pictus), among others, as indicated below, promotes Cardiomyocyte survival and protects against myocardial infarction via up-regulation of PNUTS
Salicornia herbacea L
Thus, by treating myocardial patients with Methyl 3,5-dicaffeoyl quinate (MDQ), one may prevent ageing-associated (or, stress-associated) decline in cardiac function. Together, this study suggests that pharmacological formulationsencompassing “Methyl 3,5-dicaffeoyl quinate (MDQ) or its analogues” may be used to improve cardiac function after myocardial infarction.
Idea Proposed/Formulated (with experimental evidence) by:
Dr L Boominathan Ph.D.
Web:http://genomediscovery.org or http://newbioideas.com
To cite: Boominathan, L., Natural product therapy for Myocardial Infarction: Methyl 3,5-dicaffeoyl quinate (MDQ), found in Kalopanax pictus, Salicornia herbacea L., Aster oharai and Solidago virga-aurea var. gigantean, improves myocardial function after myocardial infarction via up-regulation of PNUTS, 6/November/2016, 10.29 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
Undisclosed information: How Methyl 3,5-dicaffeoyl quinate (MDQ) increases the expression of PNUTS
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Amount: $300#
Results guaranteed if not refunded
# Research cooperation